Harrow Health Inc Live Stock Price Today, Share Analysis and Chart

Name: Harrow Health Inc: Is Infosys Ltd. worth buying?
Item: Harrow Health Inc
Rating: 2.124541625
Author: Trendlyne DVM scores

Expensive Performer

about

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to m...

40.90 0.37 (0.91%)

25.43% Fall from 52W High

469.1K

XNAS Volume

XNAS 01 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Harrow Health Inc is on 12 May 2026 for the purpose of Harrow Inc First Quarter Earnings Conference Call for 2026 See details

Medium Financial Strength

50.0 / 100

Expensive Valuation

15.8 / 100

Technically Neutral

54.1 / 100

Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM

1Yr Price target upside is 67%

8 analysts

Harrow Health Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Harrow Health Inc Live Stock Price Today, Share Analysis and Chart

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to m...

25.43% Fall from 52W High

SWOT Analysis

Harrow Health Inc Live Price Chart